New Marker of Platelet Activation, SCUBE1, Is Elevated in Hypertensive Patients
| Autor: | Gulsum Ozkan, Ahmet Mentese, Sukru Ulusoy, Muammer Cansiz, S. Caner Karahan |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Adult
Male medicine.medical_specialty Blood Pressure Enzyme-Linked Immunosorbent Assay Fibrinogen Severity of Illness Index chemistry.chemical_compound Internal medicine Internal Medicine medicine Humans Platelet activation Endothelial dysfunction Blood urea nitrogen Prothrombin time medicine.diagnostic_test business.industry Calcium-Binding Proteins Membrane Proteins Platelet Activation medicine.disease Blood pressure Endocrinology chemistry Hypertension Uric acid Female business Biomarkers Follow-Up Studies medicine.drug Partial thromboplastin time |
| Zdroj: | American Journal of Hypertension. 26:748-753 |
| ISSN: | 1941-7225 0895-7061 |
| DOI: | 10.1093/ajh/hpt007 |
| Popis: | BACKGROUND Hypertension is associated with an increase in platelet activation and endothelial dysfunction and leads to a tendency to cardiovascular events (CVEs). Signal peptide-CUB-EGF domain-containing protein 1 (SCUBE1) is a novel platelet activation marker. There are currently no studies showing the level of SCUBE1 in hypertensive patients. The purpose of this study was to determine the level of SCUBE1 in this patient group and to investigate the parameters affecting that level. METHODS Forty-five newly diagnosed, untreated, stage 1 hypertensive patients and 21 healthy individuals were included. Blood specimens were collected to determine SCUBE1, soluble CD40 ligand, prothrombin time, partial thromboplastin time, fibrinogen, D dimer, hemogram, lipid parameters, blood urea nitrogen, creatinine, and uric acid levels. The relation between SCUBE1 level and demographic data and biochemical parameters was then investigated. RESULTS SCUBE1 and sCD40L levels obtained from plasma specimens from the hypertensive group were significantly higher than those of the control group (P < 0.001; P < 0.05, respectively). Hypertensive group blood pressure (BP) values and uric acid, low-density lipoprotein, total cholesterol, and triglyceride levels were also statistically higher than those of the control group. Parameters affecting SCUBE1 levels were systolic and diastolic BP, sCD40L, lipid parameters, and uric acid levels. CONCLUSIONS We show elevated levels of SCUBE1, a novel platelet activation marker, in primary hypertensive patients. We think that, when supported by further clinical studies, this newly described marker may be useful in the monitoring of CVEs in this patient group, in which platelet activation is known to be associated with such events. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|